Open in interactive viewer → charts, metric popovers & call review

Chemtrade's Sulphur Tailwind and a Silicon Option It Won't Quite Confirm

A 2027 EBITDA 'arrow up', a raw-material headwind that flips into a tailwind, and a CEO musing about a world-scale Arizona acid plant — just as the AI-semis tape de-rates.
CHE-UN.TO · Earnings Call · 2026-11-16

The quarter that skipped the speech

Chemtrade Logistics Income Fund opened its Q3 2026 call with a disclaimer and nothing else. No prepared remarks, straight to questions — which Ben Isaacson of Scotiabank greeted with “Thank you for going straight to Q&A. It's a great best practice.” — Ben Isaacson, Analyst · 2026-11-16 For a $1.1 billion-market-cap chemical income fund, that is a tell: management had nothing new to declare, and everything to defend. So the story of this report is not the quarter. It is what the Q&A revealed about 2027 — and about a small option that management has started to talk about out loud.

The arrow, and what it is made of

Hamir Patel of CIBC asked the only question that matters for a stock like this: put all the puts and takes together, is 2027 EBITDA up? Scott Rook's answer was unusually direct for a company that normally hides behind January guidance: “So basically, yes, I think, Hamir, I won't comment on the magnitude of the arrow up because we'll be releasing the magnitude of the arrow up in January. But generally, yes, I think that points to arrow up next year.” — Scott Rook, Chief Executive Officer · 2026-11-16 That arrow — a word the CEO leaned on twice — is built from four unusually clean blocks. Water gets a lower raw-material base plus the first full year of organic growth projects. The electrochem plant has no biennial turnaround next year, which on prior disclosure is worth roughly “in that $15 million range” — Rohit Bhardwaj, Chief Financial Officer · 2026-05-12 of avoided cost. Corporate costs are flat. And merchant acid — the segment that carried this year — is expected to moderate. Which is the interesting part: 2027 is a year where the profit pool rotates, not just grows.

Sulphur switches sides

For four consecutive calls, sulphur was the villain. In May, Rohit Bhardwaj explained that roughly “20% of the world's sulfur comes through the Strait of Hormuz” — Rohit Bhardwaj, Chief Financial Officer · 2026-05-12 — a macro accident, born of the same Middle East conflict that dominated market keyword flow earlier this year, arriving at the worst moment for a business that sells water-treatment chemicals on annual fixed-price contracts to over a thousand municipalities. Now it reverses. Scott Rook opened the call with it: “we've already seen sulphur prices drop. And so -- our anticipation is that sulphur is going to be lower in '27.” — Scott Rook, Chief Executive Officer · 2026-11-16 Because those municipal contracts were struck at peak sulphur and are now locked for a year, a falling input cost is pure margin — a fixed price set yesterday against a cost realised tomorrow. But it is not free money, and management said so quietly. The very same sulphur decline that lifts water margin compresses merchant acid, where the company has spent 2026 passing costs through and pocketing a byproduct-acid spread. Rohit was explicit that acid strength is “really coming from the ASP segment. Merchant acid has been performing really well.” — Rohit Bhardwaj, Chief Financial Officer · 2026-11-16 In 2027 that crutch gets shorter. The arrow points up, but it points up from a different segment.

The silicon option, stated out loud

Then there is the genuinely new thing. Chemtrade's ultrapure sulphuric acid business has qualified two of the four large North American semiconductor manufacturers' fabs, with two more in process and more approvals guided for 2027. That is the known, grinding, sample-by-sample story — the one that has been advanced node qualification for six quarters running. What is new is the scale talk. Asked how he would evolve with the fab buildout, Rook went past brownfield debottlenecking:

we will continue to look at adding capacity -- adding capacity at our sites, but we're also beginning to look and ask ourselves what would it take to -- what would we need to be convinced of in order to restart, let's say, our efforts out in Arizona. And I wouldn't read too much into that. I just wanted to say, we're spending a lot of time looking at it, and we think that -- we think there is definitely a market opportunity for a world-scale plant.

Scott Rook, Chief Executive Officer · 2026-11-16
Read the hedge: 'I wouldn't read too much into that.' Then read the rest: a world-scale plant, and a restart of Arizona — a site never named in the prior two calls, where the language stayed anchored to Cairo and Tulsa. In the company's own keyword flow, adding capacity has climbed to near the top of the rankings for the first time, alongside talk of several different chemistries available for water acquisitions. This is a company describing optionality it has not described before. And the demand logic is not company-invented. Applied Materials, reporting the same week, leaned on data center buildouts and fab equipment demand — the same steel-in-the-ground that Rook says is now coming online 'rather quickly.' Rook's customer-confidence claim is the crux: “I will say 100% of the fabs strongly, and I'll just say they strongly want domestic supply for sulphuric acid.” — Scott Rook, Chief Executive Officer · 2026-11-16 Here is the tension, though. Over the last 30 to 90 days the market has been busy de-rating precisely that complex — co-packaged optics down roughly a third over three months, High Bandwidth Memory and high-volume production names similarly marked down. Chemtrade is talking about a multi-hundred-million-dollar world-scale plant into a tape that is currently paying less, not more, for that end market.

North Van got quieter — not smaller

A quarter ago, the judicial review of the District of North Vancouver's approval was the single most-discussed topic on the call. Today it did not crack the top thirty keywords. The dispute has not vanished; the calendar has just moved it out of trading range:

we are anticipating that, that will go in front of a judge around mid-year next year. And then after the judge hears the case, then the judge would have 3 to 4 months to write a decision and make that public.

Scott Rook, Chief Executive Officer · 2026-11-16
The money has drifted, too. On the prior call an analyst framed the program as $75 million to $105 million; today the number under discussion is $75 million to $125 million, spread across four to five years and, crucially, gated on long-lead-time orders that would have to be placed in 2027. Capital allocation stays anchored on a 2.5x leverage target, with the buyback and water M&A — North Van is 'a relatively modest number' in Scott's framing, so it does not crowd out either.

What did not change

Caustic soda. Four calls in a row, the same sentence in different clothes. In August: “The outlook is for gradual and modest increase in caustic soda.” — Scott Rook, Chief Executive Officer · 2026-08-13 In November: CMA still forecasts a rise, 70% of Asian variable cost is electricity, the timing has proven hard. The only new information is the conviction that spot Asia is uneconomic — “they're really not that sustainable and either they are at cash costs or even maybe slightly below cash cost.” — Rohit Bhardwaj, Chief Financial Officer · 2026-11-16 That is not a thesis; it is a floor argument, and it has been the floor argument for a year. The offsetting detail worth crediting: the commercial team is trying to “decouple kind of domestic pricing with the index” — Rohit Bhardwaj, Chief Financial Officer · 2026-11-16, and 95% of the Q3 netback decline came from chlorine and hydrochloric, not caustic. Chemtrade is slowly making itself less of a price-taker in the one commodity it cannot control.

The bottom line

Chemtrade is simultaneously de-risking and re-risking. De-risking: sulphur flips from headwind to tailwind, a turnaround disappears, corporate costs flatten, and the balance sheet stays at target with a live buyback. Re-risking: a world-scale acid plant in Arizona, aimed at a semiconductor supply chain that the equity tape has spent the last quarter marking down. Rook's own assurance that the business is “absolutely no, not even close to not being on the positive side” — Rohit Bhardwaj, Chief Financial Officer · 2026-11-16 of free cash flow at bottom-of-cycle prices is the thing that lets him flirt with the second. Whether the market pays for it in January, when the magnitude of the arrow lands, is a different question.